Scilex Holding Co. (SCLX)
5.04
-0.33
(-6.15%)
USD |
NASDAQ |
Sep 18, 16:00
5.09
+0.05
(+0.99%)
After-Hours: 20:00
Scilex Free Cash Flow : -61.82M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -61.82M |
| March 31, 2026 | -42.07M |
| December 31, 2025 | -12.86M |
| September 30, 2025 | 23.49M |
| June 30, 2025 | 20.14M |
| March 31, 2025 | 15.27M |
| December 31, 2024 | 18.81M |
| September 30, 2024 | 10.91M |
| June 30, 2024 | 11.90M |
| March 31, 2024 | -3.787M |
| Date | Value |
|---|---|
| December 31, 2023 | -20.92M |
| September 30, 2023 | -36.51M |
| June 30, 2023 | -39.80M |
| March 31, 2023 | -38.50M |
| December 31, 2022 | -41.49M |
| September 30, 2022 | -47.92M |
| June 30, 2022 | -50.70M |
| March 31, 2022 | -38.62M |
| December 31, 2021 | -28.38M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oramed Pharmaceuticals, Inc. | -5.820M |
| Semnur Pharmaceuticals, Inc. | -10.49M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.723M |
| Cash from Investing (Quarterly) | 8.452M |
| Cash from Financing (Quarterly) | -4.491M |
| Free Cash Flow Per Share (Quarterly) | -1.832 |
| Free Cash Flow to Equity (Quarterly) | -12.25M |
| Free Cash Flow to Firm (Quarterly) | -6.521M |
| Free Cash Flow Yield | -151.3% |